Innovation and Challenges in Preventive Cardiology: Highlights From ESC Preventive Cardiology 2025
- PMID: 40705513
- DOI: 10.1097/FJC.0000000000001741
Innovation and Challenges in Preventive Cardiology: Highlights From ESC Preventive Cardiology 2025
Keywords: cardiovascular medicine; networking; prevention.
Conflict of interest statement
G. Biondi-Zoccai has consulted for Abiomed, Advanced Nanotherapies, Aleph, Amarin, Balmed, Cardionovum, Crannmedical, Endocore Lab, Eukon, Guidotti, Innovheart, Meditrial, Menarini, Microport, Opsens Medical, Terumo, and Translumina, outside the present work. The remaining authors report no conflicts of interest.
References
-
- Abbate A, Biondi-Zoccai G, Altara R, et al. Changes for 2025 at Journal of Cardiovascular Pharmacology: introducing our junior associate editors, podcasts, feature, and new board members. J Cardiovasc Pharmacol. 2025;85:239–242.
-
- Aktaa S, Gencer B, Arbelo E, et al. European Society of Cardiology Quality indicators for cardiovascular disease prevention: developed by the Working Group for cardiovascular disease prevention Quality indicators in collaboration with the European Association for preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2022;29:1060–1071.
-
- Martínez-Gómez J, Fernández-Alvira JM, de Cos-Gandoy A, et al. Sleep duration and its association with adiposity markers in adolescence: a cross-sectional and longitudinal study. Eur J Prev Cardiol. 2023;30:1236–1244.
-
- Peikert A, Vaduganathan M, Claggett BL, et al. Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. Eur Heart J. 2025;46:2372–2390.
-
- Miller RJH, Yi J, Shanbhag A, et al. Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study. Eur Heart J. 2025;46:2336–2347.
LinkOut - more resources
Full Text Sources
